Clinical Trial

Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The benefit of intravenous tenecteplase in very old patients with acute ischemic stroke (AIS) remain uncertain. This real-world study aims to evaluate the effectiveness and safety of intravenous tenecteplase in AIS patients aged 80 years or older within 4.5 hours of symptom onset.
Trial Details
NCT Number NCT07475936
Lead Sponsor First Affiliated Hospital of Guangxi Medical University
Conditions Acute Ischemic Stroke, Tenecteplase
Enrollment 392 participants
Start Date 2026-04
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-17